FIELD: agriculture; veterinary science.
SUBSTANCE: the method consists in single dosing of 0.01% "Phosphopag" solution dose - 100.0 ml and "Ekos" dose - 150.0 mg/kg of live weight. Both medicines are introduced into feed regimen.
EFFECT: allows compensating quickly the risk of thrombocytopathy development of newborn calves with dyspepsia and prevents from relapse development.
2 ex
Title | Year | Author | Number |
---|---|---|---|
NEWBORN CALVES WITH DYSPEPSIA THROMBOCYTE ABNORMALITIES PROPHYLAXIS METHOD | 2006 |
|
RU2323731C1 |
METHOD FOR TREATMENT THROMBOCYTE DISORDER IN DYSPEPTIC NEWBORN CALVES | 2006 |
|
RU2333749C1 |
METHOD OF TEATMENT OF THROMBOCYTOPATHY IN NEWBORN CALFS WITH DYSPEPSIA | 2006 |
|
RU2324487C2 |
METHOD OF NEWBORN CALVES DYSPEPSIA TREATMENT | 2006 |
|
RU2329812C1 |
METHOD OF DISPERSION TREATMENT IN NEWBORN CALVES AND PIGLETS | 2007 |
|
RU2356542C1 |
METHOD OF NEWBORN CALVES' DYSPEPSIA TREATMENT | 2006 |
|
RU2327467C1 |
METHOD OF PREVENTION OF THROMBOCYTE DISORDERS ACCOMPANYING DYSPEPSIA OF NEWBORN CALVES | 2006 |
|
RU2328290C1 |
METHOD OF PREVENTION OF THROMBOCYTE DISORDER CAUSED BY NEWBORN CALF'S DYSPEPSIA | 2006 |
|
RU2327466C1 |
METHOD OF HAEMOSTASIS NORMALISATION FOR NEWBORN CALVES BORN OF COWS HAVING HAD BANE POISONING DURING PREGNANCY PERIOD | 2006 |
|
RU2329792C1 |
METHOD FOR EARLIER DETECTION OF THE RISK OF DEVELOPING THROMBOCYTIC DISORDERS IN ANIMALS | 2006 |
|
RU2316767C2 |
Authors
Dates
2008-05-10—Published
2006-11-27—Filed